Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by hmmmmmmmmon Feb 24, 2023 4:40pm
176 Views
Post# 35304463

.68 on this day 2021

.68 on this day 2021Take a look at our SP chart under the Seto and Kellum's control.

The share price is a direct reflection of their inability to deliver anything close to their promises on the Tigris trial enrollment. (nevermind DIMI/ SAMI)

I believe in PMX 
but Seto? Kellum have proved month after month that they can not solve the enrollment problem- putting all of our future retuns jeopardy.

Instead of facing up to their problems and making real changes- mangement instead just removed their timeline chart from the latest Investor Update.

It seems Seto and Kellum can't stomach repeating the same false statements.
<< Previous
Bullboard Posts
Next >>